Abstract
A 43 year old lady is referred with an asymptomatic visual field defect which leads to the diagnosis of neurofibromatosis-1.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol. 2011;31:269–78.
Dutton JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol. 1994;38:427–52.
Mishra MV, Andrews DW, Glass J, Evans JJ, Dicker AP, Shen X, Lawrence YR. Characterization and outcomes of optic nerve gliomas: a population-based analysis. J Neurooncol. 2012;107:591–7.
Fried I, Tabori U, Tihan T, Reginald A, Bouffet E. Optic pathway gliomas: a review. CNS Oncol. 2013;2:143–59.
Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol. 2012;14:790–7.
Ferner RE, Gutmann DH. Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol. 2013;115:939–55.
Niemeyer CM. RAS diseases in children. Haematologica. 2014;99:1653–62.
Madanikia SA, Bergner A, Ye X, Blakeley JO. Increased incidence of breast cancer in women with NF1. Am J Med Genet. 2012;158A:3056–60.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag London Limited
About this chapter
Cite this chapter
Kidd, D.P. (2017). Case 16. In: Neuro-Ophthalmology. Springer, London. https://doi.org/10.1007/978-1-4471-2410-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2410-8_16
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2409-2
Online ISBN: 978-1-4471-2410-8
eBook Packages: MedicineMedicine (R0)